Hemispherian Competitors and Similar CompaniesClear all
Hemispherian's competitors and similar companies include Xencor and CyTuVax.
 Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. |  CyTuVax CyTuVax is a company that develops therapeutic vaccines against cancer and protective vaccines against viral and bacterial pathogens. | ||
Founding Date | Founding Date 2015 | Founding Date 1997 | Founding Date 2012 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Oslo, NO HQ | Locations Pasadena, US HQ San Diego, US | Locations Maastricht, NL HQ |
Employees | Employees 10 | Employees 2604% increase | Employees N/A |
Funding | |||
Total funding raised | Total funding raised $ 9.8m | Total funding raised $ 108.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Xencor
HQ
Pasadena, US
Employees
260↑ 4% increase
Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
View companyCyTuVax
HQ
Maastricht, NL
CyTuVax is a company that develops therapeutic vaccines against cancer and protective vaccines against viral and bacterial pathogens.
View company